The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Surgical Treatment of Moderate Ischemic Mitral Regurgitation
Open accessAbstract
BACKGROUND: Ischemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain. METHODS: We randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank. RESULTS: At 1 year, the mean LVESVI among surviving patients was 46.1±22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6±31.5 ml per square meter in the combined-procedure group (mean change from baseline, -9.4 and -9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P=0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P=0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P=0.002), and more neurologic events (P=0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year. CONCLUSIONS: In patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Self-citationCardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Research works printed but not linked: 39
- 10.1161/01.cir.0000441139.02102.80 · DOI · Paper page
- 10.1161/01.CIR.0000151097.30779.04 · DOI · Paper page
- 10.1093/eurheartj/ehm469 · DOI
- 10.1161/01.CIR.96.3.827 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.113.005223 · DOI
- 10.1016/j.jacc.2004.10.030 · DOI · Paper page
- 10.1161/01.CIR.76.4.777 · doi:10.1161/01.cir.76.4.777
- 10.1016/0735-1097(92)90455-V · DOI · Paper page
- 10.1161/01.CIR.102.12.1400 · doi:10.1161/01.cir.102.12.1400
- 10.1067/mtc.2003.78 · doi:10.1067/mtc.2003.78
- 10.1016/j.athoracsur.2004.07.040 · doi:10.1016/j.athoracsur.2004.07.040
- Schroder JN, 2005, Circulation, 112, I, 10.1161/CIRCULATIONAHA.104.523472 · doi:10.1161/circulationaha.104.523472
- 10.1016/j.athoracsur.2010.03.103 · DOI
- 10.1016/j.jtcvs.2003.09.010 · doi:10.1016/j.jtcvs.2003.09.010
- Christenson JT, 1995, J Heart Valve Dis, 4, 484
- 10.1161/CIRCULATIONAHA.108.842104 · doi:10.1161/circulationaha.108.842104
- 10.1111/j.1540-8175.2006.00163.x · doi:10.1111/j.1540-8175.2006.00163.x
- 10.1016/j.jtcvs.2008.12.023 · doi:10.1016/j.jtcvs.2008.12.023
- 10.1161/01.CIR.0000138196.06772.4e · DOI · Paper page
- 10.1016/j.jtcvs.2011.10.029 · DOI · Paper page
- 10.1016/j.athoracsur.2010.11.009 · DOI · Paper page
- 10.1016/j.jtcvs.2011.05.006 · doi:10.1016/j.jtcvs.2011.05.006
- 10.1016/S0894-7317(03)00335-3 · DOI · Paper page
- 10.2307/2530245 · DOI · Paper page
- 10.2307/2336502 · DOI · Paper page
- 10.1161/hc37t1.094706 · doi:10.1161/hc37t1.094706
- 10.1161/CIRCULATIONAHA.111.072256 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.105.000398 · DOI
- 10.1016/j.athoracsur.2008.05.017 · doi:10.1016/j.athoracsur.2008.05.017
- 10.1016/S1010-7940(01)00770-9 · doi:10.1016/s1010-7940(01)00770-9
- 10.1016/j.athoracsur.2005.03.034 · doi:10.1016/j.athoracsur.2005.03.034
- 10.1016/j.athoracsur.2004.11.005 · doi:10.1016/j.athoracsur.2004.11.005
- 10.1016/j.jacc.2011.08.009 · DOI · Paper page
- 10.1016/j.jtcvs.2012.09.007 · DOI · Paper page
- 10.1016/j.jtcvs.2008.11.010 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.112.143818 · DOI · Paper page
- 10.1161/01.CIR.76.1.44 · DOI · Paper page
- 10.1054/j.cardfail.2003.09.001 · DOI
- 10.1054/jcaf.2003.22 · DOI
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Metadata
- Authors
- Smith, P. K., Puskas, J. D., Ascheim, D. D., Voisine, P., Gelijns, A. C., Moskowitz, A. J., Hung, J. W., Parides, M. K., Ailawadi, G., Perrault, L. P., Acker, M. A., Argenziano, M., Thourani, V., Gammie, J. S., Miller, M. A., Pagé, P., Overbey, J. R., Bagiella, E., Dagenais, F., Blackstone, E. H., Kron, I. L., Goldstein, D. J., Rose, E. A., Moquete, E. G., Jeffries, N., Gardner, T. J., O'Gara, P. T., Alexander, J. H., & Michler, R. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-12-04
- Volume
- 371
- Issue
- 23
- Pages
- 2178-2188
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160191160
- Cited by
- 421
- References
- 3
- FWCI
- 34.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surgical Treatment of Moderate Ischemic Mitral Regurgitation. https://app.cochat.ai/papers/10.1056/nejmoa1410490
- The paper
- Smith, P. K., Puskas, J. D., Ascheim, D. D., Voisine, P., Gelijns, A. C., Moskowitz, A. J., Hung, J. W., Parides, M. K., Ailawadi, G., Perrault, L. P., Acker, M. A., Argenziano, M., Thourani, V., Gammie, J. S., Miller, M. A., Pagé, P., Overbey, J. R., Bagiella, E., Dagenais, F., . . . Michler, R. E. (2014). Surgical Treatment of Moderate Ischemic Mitral Regurgitation. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1410490
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.